Burzynski: GLIOBLASTOMA MULTIFORME (GBM)

� � � � � � � � � � � � � � � � �
# and % of Patients Resolving or Stabilizing Disease = Complete Response + Partial Response + Stable Disease
——————————————————————
14 / 63.5 – 10/2004 Antineoplastons: Protocol – GLIOBLASTOMA MULTIFORME (GBM) which recurred or progressed post surgery, radiation therapy, and / or chemotherapy
======================================
# and % of Patients Showing Objective Response = Complete Response + Partial Response
——————————————————————
2 / 9% – 10/2004 Antineoplastons: Protocol – GLIOBLASTOMA MULTIFORME (GBM) which recurred or progressed post surgery, radiation therapy, and / or chemotherapy
======================================
# and % of Patients Showing Complete Response
——————————————————————
1 / 4.5% – 10/2004 Antineoplastons: Protocol – GLIOBLASTOMA MULTIFORME (GBM) which recurred or progressed post surgery, radiation therapy, and / or chemotherapy
======================================
# and % of Patients Showing Partial Response
——————————————————————
1 / 4.5% – 10/2004 Antineoplastons: Protocol – GLIOBLASTOMA MULTIFORME (GBM) which recurred or progressed post surgery, radiation therapy, and / or chemotherapy
======================================
# and % of Patients Showing Stable Disease
——————————————————————
12 / 54.5% – 10/2004 Antineoplastons: Protocol – GLIOBLASTOMA MULTIFORME (GBM) which recurred or progressed post surgery, radiation therapy, and / or chemotherapy
======================================
# and % of Patients Showing Progressive Disease
——————————————————————
8 / 36.5% – 10/2004 Antineoplastons: Protocol – GLIOBLASTOMA MULTIFORME (GBM) which recurred or progressed post surgery, radiation therapy, and / or chemotherapy
� � � � � � � � � � � � � � � � �

� � � � � � � � � � � � � � � � �
Maximum Survival (MS):
——————————————————————
26% – 6/1/2003 Antineoplastons – Protocol – GLIOBLASTOMA MULTIFORME 3/2004 (Pg. 48)
======================================
17+ years – 6/1/2003 Antineoplastons: Protocol – GLIOBLASTOMA MULTIFORME 3/2004 (Pg. 48)

11+ years – 6/1/2003 – Protocol – GLIOBLASTOMA MULTIFORME (Pg. 54)
======================================
1 Surviving who exhibited Objective Response (OR):
——————————————————————
11+ years – 6/1/2003 Antineoplastons: Protocol – GLIOBLASTOMA MULTIFORME 2004 (Pg. 55)
======================================
Surviving:
——————————————————————
9+ years – 6/1/2003 Antineoplastons: Protocol – GLIOBLASTOMA MULTIFORME 2004 (Pg. 55)
======================================
Maximum Overall Survival:
——————————————————————
8+ years – 10/2004 recurrent GLIOBLASTOMA MULTIFORME (GBM) (Pgs. 384-385)
======================================
2 Patients have been Surviving Post Diagnosis:
——————————————————————
7+ years – 6/1/2003 Antineoplastons: Protocol – GLIOBLASTOMA MULTIFORME 2004 (Pg. 55)
======================================
Median Overall Survival from start of Treatment (OST) with the Majority of Patients Alive:
——————————————————————
5.1 years – 6/1/2003 Antineoplastons: Protocol – GLIOBLASTOMA MULTIFORME 3/2004 (Pg. 48)
======================================
5 year Progression-Free Survival (PFS):
——————————————————————
34 / 26% – GLIOBLASTOMA MULTIFORME (GBM): after radical surgery – 1998 Protocol: High-Grade ASTROCYTOMA – Surgery: Wisoff JH, Boyett JM, Berger MS, et al. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children’s Cancer Group trial no. CCG-945. J Neurosurg 1998; 89: 52-9 131 (Pg. 171 + 176) 2006
======================================
5 year Progression-Free Survival (PFS):
——————————————————————
5 / 4% – GLIOBLASTOMA MULTIFORME (GBM): less aggressive surgery – 1998 Protocol: High-Grade ASTROCYTOMA – Surgery: Wisoff JH, Boyett JM, Berger MS, et al. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children’s Cancer Group trial no. CCG-945. J Neurosurg 1998; 89: 52-9 131 (Pg. 171 + 176) 2006
======================================
3 Surviving:
——————————————————————
3 years approximately – 6/1/2003 Antineoplastons: Protocol – GLIOBLASTOMA MULTIFORME 2004 (Pg. 55)
======================================
% of Objective Response (OR) Patients hadn’t Progressed:
——————————————————————
53% – 6/1/2003 Antineoplastons: Protocol – GLIOBLASTOMA MULTIFORME (Pg. 54)
======================================
Progression-Free Survival (PFS):
——————————————————————
2 years – 1 Patient – Progressed after 24 months 6/1/2003 Antineoplastons: Protocol – GLIOBLASTOMA MULTIFORME 3/2004 (Pg. 48)
======================================
Median Overall Survival from Diagnosis (OSD):
——————————————————————
15 months (1 year 3 months) –
======================================
Median Survival:
——————————————————————
15 months (1 year 3 months) – 6/1/2003 Antineoplastons: Protocol – glioma of the highest malignancy, recurrent GLIOBLASTOMA MULTIFORME (GBM) (Pg. 55)

6.5 months (26.9 weeks) – 4/2003 recurrent GLIOBLASTOMA MULTIFORME (GBM) with newest forms of Chemotherapy (Prados et al.). 62 – carboplatin + x (Pg. 58)

4 months 3.9 weeks (19.9 weeks) – 4/2003 recurrent GLIOBLASTOMA MULTIFORME (GBM) with newest forms of Chemotherapy (Prados et al.). 60 – carboplatin + placebo (Pg. 58)
======================================
Median Overall Survival:
——————————————————————
9.2 months – 10/2004 recurrent GLIOBLASTOMA MULTIFORME (GBM)
======================================
Median Overall Survival from start of Treatment (OST):
——————————————————————
9 months – 6/1/2003 Antineoplastons: Protocol – GLIOBLASTOMA MULTIFORME (Pg. 54)
======================================
Newest forms of chemotherapy:
——————————————————————
Less than 7 months – 6/1/2003 (2004) (Pg. 55)
======================================
Progression-Free Survival (PFS):
——————————————————————
11 / 50% – 6 months – 10/2004 recurrent GLIOBLASTOMA MULTIFORME (GBM)
======================================
Progression-Free Survival (PFS):
——————————————————————
5 months – 6/1/2003 Antineoplastons: Protocol – GLIOBLASTOMA MULTIFORME (Pg. 54)
======================================
no treatment
——————————————————————
4 months – (Pg. 58)
======================================
Median Survival – Untreated Patients:
——————————————————————
4 months – 6/1/2003 (2004) (Pg. 55)
Deceased or Status Unknown:
======================================
� � � � � � � � � � � � � � � � �

� � � � � � � � � � � � � � � � �
Burzynski: Complete Response, Partial Response, Stable Disease, Progressive Disease, Objective Response, and Response:
https://stanislawrajmundburzynski.wordpress.com/2013/07/04/burzynski-complete-response-partial-response-stable-disease-progressive-disease-objective-response-and-response/
� � � � � � � � � � � � � � � � �
Burzynski: Progression-Free Survival:
https://stanislawrajmundburzynski.wordpress.com/2013/07/04/burzynski-progression-free-survival/
� � � � � � � � � � � � � � � � �

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s